John G. Clohessy

6.6k citations

50 papers · 3.7k indexed · 1 hit paper · h-index 28

Molecular Biology top 2%
Cancer Research top 1%
Oncology top 5%
Immunology top 10%
Pulmonary and Respiratory Medicine top 10%

Co-authors: Pier Paolo Pandolfi Caterina Nardella Andrea Alimonti Emanuele Monteleone Akinobu Matsumoto Arkaitz Carracedo Alessandra Pasut Hugh J.M. Brady
Topics: RNA Research and Splicing (10 papers)PI3K/AKT/mTOR signaling in cancer (7 papers)RNA modifications and cancer (7 papers)
Cited by: Cancer Research Molecular Biology Oncology
Journals: Nature Cell Journal of Biological Chemistry
Partner nations: United States Italy Singapore

In The Last Decade

John G. Clohessy

50 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

mTORC1 and muscle regeneration are regulated by the LINC00961-encoded SPAR polypeptide

2016 489 citations Akinobu Matsumoto, Jacqueline Fung et al. Nature profile →

Peers

Countries citing papers authored by John G. Clohessy

Since Specialization

Citations

This map shows the geographic impact of John G. Clohessy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John G. Clohessy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John G. Clohessy more than expected).

Fields of papers citing papers by John G. Clohessy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John G. Clohessy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John G. Clohessy. The network helps show where John G. Clohessy may publish in the future.

Co-authorship network of co-authors of John G. Clohessy

This figure shows the co-authorship network connecting the top 25 collaborators of John G. Clohessy. A scholar is included among the top collaborators of John G. Clohessy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John G. Clohessy. John G. Clohessy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting Cholesterol Biosynthesis with Statins Synergizes with AKT Inhibitors in Triple-Negative Breast Cancer 2024 ·Cancer Research ·(unknown),Timothy D. Martin,Haley E. Manchester,(unknown),(unknown),(unknown),(unknown),(unknown),Nicole S. Persky,David E. Root,Myles Brown,Karen Cichowski,Stephen J. Elledge,Taru Muranen,(unknown),Simon T. Barry,John G. Clohessy,Ralitsa R. Madsen,Alex Toker	12
2	Toker Cell Hyperplasia in the Nipple-Areolar Complex of Transmasculine Individuals 2023 ·Modern Pathology ·Gabrielle M. Baker,(unknown),(unknown),Valerie Fein‐Zachary,Adam M. Tobias,Richard A. Bartlett,John G. Clohessy,Ioannis S. Vlachos,(unknown),Gerburg M. Wulf,Stuart J. Schnitt,Yujing J. Heng	2
3	Targeting of microRNA-22 Suppresses Tumor Spread in a Mouse Model of Triple-Negative Breast Cancer 2023 ·Biomedicines ·Riccardo Panella,(unknown),(unknown),(unknown),Kelsey Berry,Samuel Lee,Felipe Batalini,Ioannis S. Vlachos,John G. Clohessy,Sakari Kauppinen,Pier Paolo Pandolfi	1
4	PI3K drives the de novo synthesis of coenzyme A from vitamin B5 2022 ·Nature ·Christian C. Dibble,(unknown),(unknown),Evan C. Lien,Renee C. Geck,(unknown),David Bartee,Thomas Zengeya,(unknown),Min Yuan,Benjamin D. Hopkins,Jordan L. Meier,John G. Clohessy,John M. Asara,Lewis C. Cantley,Alex Toker	56
5	Dual DNA and protein tagging of open chromatin unveils dynamics of epigenomic landscapes in leukemia 2021 ·Nature Methods ·Jonathan D. Lee,João A. Paulo,(unknown),Vera Mugoni,Nikki R. Kong,Giulia Cheloni,Yu-Ru Lee,Frank J. Slack,Daniel G. Tenen,John G. Clohessy,Steven P. Gygi,Pier Paolo Pandolfi	7
6	Author Correction: Intragenic antagonistic roles of protein and circRNA in tumorigenesis 2020 ·Cell Research ·Jlenia Guarnerio,Yang Zhang,Giulia Cheloni,Riccardo Panella,Jesse Katon,Mark Simpson,Akinobu Matsumoto,Antonella Papa,Cristian Loretelli,Andreas Petri,Sakari Kauppinen,Cassandra C. Garbutt,G. Petur Nielsen,Vikram Deshpande,Mireia Castillo-Martín,Carlos Cordon‐Cardo,Dimitrios Spentzos,John G. Clohessy,Mona Batish,Pier Paolo Pandolfi	2
7	Intragenic antagonistic roles of protein and circRNA in tumorigenesis 2019 ·Cell Research ·Jlenia Guarnerio,Yang Zhang,Giulia Cheloni,Riccardo Panella,Jesse Katon,Mark Simpson,Akinobu Matsumoto,Antonella Papa,Cristian Loretelli,Andreas Petri,Sakari Kauppinen,Cassandra C. Garbutt,G. Petur Nielsen,Vikram Deshpande,Mireia Castillo-Martín,Carlos Cordon‐Cardo,Dimitrios Spentzos,John G. Clohessy,Mona Batish,Pier Paolo Pandolfi	128
8	CAV1 - GLUT3 signaling is important for cellular energy and can be targeted by Atorvastatin in Non-Small Cell Lung Cancer 2019 ·Theranostics ·Azhar Ali,Elena Levantini,Chee Wai Fhu,(unknown),John G. Clohessy,Julian Goggi,Chan-Shuo Wu,Leilei Chen,Tan Min Chin,Daniel G. Tenen	34
9	Pericytes Elicit Resistance to Vemurafenib and Sorafenib Therapy in Thyroid Carcinoma via the TSP-1/TGFβ1 Axis 2018 ·Clinical Cancer Research ·Alessandro Prete,Agnes S. Lo,Peter M. Sadow,Swati S. Bhasin,Zeus A. Antonello,(unknown),Soumya Ullas,Jennifer N. Sims,John G. Clohessy,Ann M. Dvořàk,Tracey Sciuto,Manoj Bhasin,Joanne E. Murphy-Ullrich,Jack Lawler,S. Ananth Karumanchi,Carmelo Nucera	46
10	Diverse genetic-driven immune landscapes dictate tumor progression through distinct mechanisms 2018 ·Nature Medicine ·Marco Bezzi,Nina Seitzer,T. Ishikawa,Markus Reschke,Ming Chen,Guocan Wang,(unknown),Christopher Ng,Jesse Katon,Andrea Lunardi,Sabina Signoretti,John G. Clohessy,Jiangwen Zhang,Pier Paolo Pandolfi	134
11	Deregulated PP1α phosphatase activity towards MAPK activation is antagonized by a tumor suppressive failsafe mechanism 2018 ·Nature Communications ·Ming Chen,Lixin Wan,Jiangwen Zhang,Jinfang Zhang,Lourdes Mendez,John G. Clohessy,Kelsey Berry,Joshua Victor,Qing Yin,Zhu Yuan,Wenyi Wei,Pier Paolo Pandolfi	37
12	Nanoformulation of Olaparib Amplifies PARP Inhibition and Sensitizes PTEN/TP53- Deficient Prostate Cancer to Radiation 2017 ·Molecular Cancer Therapeutics ·Anne L. van de Ven,(unknown),Paige Baldwin,Ju Qiao,(unknown),Nina Seitzer,John G. Clohessy,G. Mike Makrigiorgos,Robert A. Cormack,Pier Paolo Pandolfi,Srinivas Sridhar	46
13	In Vivo Role of INPP4B in Tumor and Metastasis Suppression through Regulation of PI3K–AKT Signaling at Endosomes 2015 ·Cancer Discovery ·Chen Li Chew,Andrea Lunardi,Federico Gulluni,Daniel T. Ruan,Ming Chen,Leonardo Salmena,Michiya Nishino,Antonella Papa,Christopher Ng,Jacqueline Fung,John G. Clohessy,Junko Sasaki,Takehiko Sasaki,Roderick T. Bronson,Emilio Hirsch,Pier Paolo Pandolfi	72
14	Vulnerabilities of PTEN – TP53 -Deficient Prostate Cancers to Compound PARP–PI3K Inhibition 2014 ·Cancer Discovery ·Enrique González‐Billalabeitia,Nina Seitzer,Su Jung Song,Min Sup Song,Akash Patnaik,Xuesong Liu,Mirjam T. Epping,Antonella Papa,Robin M. Hobbs,Ming Chen,Andrea Lunardi,Christopher Ng,Kaitlyn A. Webster,Sabina Signoretti,Massimo Loda,John M. Asara,Caterina Nardella,John G. Clohessy,Lewis C. Cantley,Pier Paolo Pandolfi	80
15	The RNA Binding Protein ESRP1 Fine-Tunes the Expression of Pluripotency-Related Factors in Mouse Embryonic Stem Cells 2013 ·PLoS ONE ·Sharmila Fagoonee,Claudia Bearzi,Ferdinando Di Cunto,John G. Clohessy,Roberto Rizzi,Markus Reschke,Emanuela Tolosano,Paolo Provero,Pier Paolo Pandolfi,Lorenzo Silengo,Fiorella Altruda	36
16	Found in translation of mTOR signaling 2012 ·Cell Research ·John G. Clohessy,Markus Reschke,Pier Paolo Pandolfi	12
17	Differential Expression of S6K2 Dictates Tissue-Specific Requirement for S6K1 in Mediating Aberrant mTORC1 Signaling and Tumorigenesis 2011 ·Cancer Research ·Caterina Nardella,Andrea Lunardi,Giuseppe Fedele,John G. Clohessy,Andrea Alimonti,Sara C. Kozma,George Thomas,Massimo Loda,Pier Paolo Pandolfi	17
18	Dyskerin expression influences the level of ribosomal RNA pseudo‐uridylation and telomerase RNA component in human breast cancer 2006 ·The Journal of Pathology ·Lorenzo Montanaro,Maurizio Brigotti,John G. Clohessy,Stefania Barbieri,Claudio Ceccarelli,Donatella Santini,Mario Taffurelli,Maria Calienni,Julie Teruya‐Feldstein,Davide Treré,PP Pandolfi,Massimo Derenzini	98
19	Mcl-1 Interacts with Truncated Bid and Inhibits Its Induction of Cytochrome c Release and Its Role in Receptor-mediated Apoptosis 2005 ·Journal of Biological Chemistry ·John G. Clohessy,Jianguo Zhuang,Jasper de Boer,Gabriel Gil‐Gómez,Hugh J.M. Brady	151
20	Characterisation of Mcl‐1 cleavage during apoptosis of haematopoietic cells 2004 ·British Journal of Haematology ·John G. Clohessy,Jianguo Zhuang,Hugh J.M. Brady	68

About John G. Clohessy

John G. Clohessy is a scholar working on Cancer Research, Hematology and Molecular Biology, having authored 50 papers that have together received 3.7k indexed citations. Recurring topics across this work include RNA Research and Splicing (10 papers), PI3K/AKT/mTOR signaling in cancer (7 papers) and RNA modifications and cancer (7 papers). The work is most often cited by research in Cancer Research (1.4k citations), Molecular Biology (2.9k citations) and Oncology (756 citations). John G. Clohessy has collaborated with scholars based in United States, Italy and Singapore. Frequent co-authors include Pier Paolo Pandolfi, Caterina Nardella, Andrea Alimonti, Emanuele Monteleone, Akinobu Matsumoto, Arkaitz Carracedo, Alessandra Pasut, Hugh J.M. Brady, Jianguo Zhuang and Lloyd C. Trotman. Their work appears in journals such as Nature, Cell and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact